文献速递胃肠外科围术期管理与 ERAS

腹腔镜与机器人微创结肠切除术的成本效果评价

Cost-effectiveness Evaluation of Laparoscopic Versus Robotic Minimally Invasive Colectomy.
PubMed 文献 · Ann Surg · 2020-01-01

该研究构建决策分析模型,比较开放、腹腔镜与机器人结肠切除术的1年成本与质量调整生存时间。机器人较腹腔镜每例多花费745美元(社会视角)或1339美元(医疗部门视角),ICER分别达2,322,715美元/QALY和4,174,849美元/QALY,腹腔镜在广泛支付意愿阈值下更具成本效果。

要点

  • 腹腔镜与机器人结肠切除术的成本效果均优于开放手术。
  • 机器人较腹腔镜成本更高且QALY差异极小,ICER极高。
  • 机器人一次性器械成本、手术室时间或疝发生率达标时可具成本效果。

核心结论

  • 腹腔镜和机器人结肠切除术比开放切除更具成本效果。
  • 机器人需在生活质量、器械成本和术后结局达到特定阈值才能超越腹腔镜的成本效果。

研究设计与样本

  • 决策分析模型,评估机器人、腹腔镜与开放结肠切除术的1年成本和质量调整时间。
  • 模型输入来自现有文献的成本、生活质量与结局数据。
  • 结果以增量成本效果比(ICER)表示,即每获得一个质量调整生命年(QALY)的增量成本。
  • 进行单因素和概率敏感性分析检验临床合理变异的影响。

主要发现

  • 开放结肠切除术成本更高且生活质量低于机器人和腹腔镜。
  • 社会视角下机器人每例比腹腔镜多花费745美元,ICER为2,322,715美元/QALY。
  • 医疗部门视角下机器人每例多花费1339美元,ICER为4,174,849美元/QALY。
  • 两种模型中腹腔镜在广泛支付意愿阈值下更常具有成本效果。

关键数值与推荐

  • 机器人每例一次性器械成本降至1341美元以下时,在100,000美元/QALY阈值下具成本效果。
  • 机器人手术室时间降至172分钟以下时,在100,000美元/QALY阈值下具成本效果。
  • 机器人疝发生率低于5%时,在100,000美元/QALY阈值下具成本效果。

临床怎么用

  • 腹腔镜结肠切除术在广泛支付意愿阈值下是更具成本效果的选择。
  • 机器人结肠切除术需优化器械成本、手术室效率和术后结局以提升成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Evaluate the cost-effectiveness of open, laparoscopic, and robotic colectomy. BACKGROUND: The use of robotic-assisted colon surgery is increasing. Robotic technology is more expensive and whether a robotically assisted approach is cost-effective remains to be determined. METHODS: A decision-analytic model was constructed to evaluate the 1-year costs and quality-adjusted time between robotic, laparoscopic, and open colectomy. Model inputs were derived from available literature for costs, quality of life (QOL), and outcomes. Results are presented as incremental cost-effectiveness ratios (ICERs), defined as incremental costs per quality-adjusted life year (QALY) gained. One-way and probabilistic sensitivity analyses were performed to test the effect of clinically reasonable variations in the inputs on our results. RESULTS: Open colectomy cost more and achieved lower QOL than robotic and laparoscopic approaches. From the societal perspective, robotic colectomy costs $745 more per case than laparoscopy, resulting in an ICER of $2,322,715/QALY because of minimal differences in QOL. From the healthcare sector perspective, robotics cost $1339 more per case with an ICER of $4,174,849/QALY. In both models, laparoscopic colectomy was more frequently cost-effective across a wide range of willingness-to-pay thresholds. Sensitivity analyses suggest robotic colectomy becomes cost-effective at $100,000/QALY if robotic disposable instrument costs decrease below $1341 per case, robotic operating room time falls below 172 minutes, or robotic hernia rate is less than 5%. CONCLUSIONS: Laparoscopic and robotic colectomy are more cost-effective than open resection. Robotics can surpass laparoscopy in cost-effectiveness by achieving certain thresholds in QOL, instrument costs, and postoperative outcomes. With increased use of robotic technology in colorectal surgery, there is a burden to demonstrate these benefits.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Simianu VV, Gaertner WB, Kuntz K, et al. Cost-effectiveness Evaluation of Laparoscopic Versus Robotic Minimally Invasive Colectomy. Ann Surg. 2020. PMID: 32675547. doi:10.1097/SLA.0000000000003196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。